The Oncology Institute, Inc. (TOI) Misses Q3 EPS by 11c

The Oncology Institute, Inc. (NASDAQ: TOI) reported Q3 EPS of ($0.18), $0.11 worse than the analyst estimate of ($0.07). Revenue for the quarter came in at $99.9 million versus the consensus estimate of $107.54 million.

For earnings history and earnings-related data on The Oncology Institute, Inc. (TOI) click here.

You May Also Be Interested In

• Movano (MOVE) Misses Q2 EPS by 195c
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15